Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs that became popular when ...

Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...

The search for more affordable medications might cause people to access dangerous counterfeit drugs sold as genuine products ...

INDIANAPOLIS - Eli Lilly and Company announced Wednesday that it will invest $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development in ...

Mike Braun and Jennifer McCormick talked about the future of Indiana's abortion laws during a debate on FOX59 Wednesday night ...

The company’s first two investments in the district were for a manufacturing site. The new site will focus on research, but ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer in shortage, according to US regulators.

Mounjaro has been on the FDA's shortage list since late 2022, while Zepbound was added to the list in April this year.

Lilly officials said a newly-announced facility near Lebanon could shorten the drug research and development cycle by up to a year or more.

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on ...

Altimmune, Inc.'s weight loss drug pemvidutide shows promise as a takeover target with superior lean mass retention and maybe ...